Acute Porphyria Drug Database

A06AD17 - Sodium Phosphate
Not porphyrinogenic
NP

Rationale
Sodium phosphate is a salt that is eliminated by the kidneys, with no hepatic involvement.
Chemical description
Sodium phosphate a salt of sodium and phosphoric acid.
Therapeutic characteristics
Sodium phosphate is an osmotically acting laxative. Concentrated oral solutions are used for bowel cleansing before surgery or endoscopy procedures. The oral solutions act within 30 minutes to 6 hours. Common adverse reactions of sodium phosphate that can be confused with an acute porphyric attack are nausea, vomiting, diarrhoea, and abdominal pain.
Metabolism and pharmacokinetics
About two-thirds of ingested phosphate is absorbed from the gastrointestinal tract. Excess phosphate is mainly excreted in the urine, the remainder being excreted in the faeces. No hepatic involvement.
IPNet drug reports
No.

References

  1. Drug reference publications
  2. Sweetman SC, editor. Martindale: The complete drug reference. Phosphate. Pharmaceutical Press 2009. #1093
  3. Summary of Product Characteristics
  4. Norwegian medicines agency. Summary of Product Characteristics (SPC). Phosphoral. #1092

Similar drugs
Explore alternative drugs in similar therapeutic classes A06A / A06AD or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙